The Microbiome as a Therapeutic Target for Metabolic Diseases

Obesity, type 2 diabetes, and fatty liver disease are now viewed through the lens of microbial imbalance. Specific gut microbes can influence energy extraction, lipogenesis, insulin sensitivity, and inflammation. This session discusses how diet, antibiotics, prebiotics, probiotics, and fecal microbiota transplantation (FMT) may serve as therapeutic strategies for metabolic syndrome, with emphasis on personalized microbial interventions based on individual microbiota profiles.